PROQR THRAPEUTICS N V
(N71542109)
ファンドの報告 PROQR THRAPEUTICS N V 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| RTW Investments LP | 3,722,950 | $33,879k | Jun 30, 2019 | Aug 14, 2019 | |
| Orbimed Advisors LLC | 1,382,502 | $12,581k | Jun 30, 2019 | Aug 14, 2019 | |
| Kerrisdale Advisers LLC | 465,580 | $4,237k | Jun 30, 2019 | Aug 14, 2019 | |
| Dafna Capital Management LLC | 261,521 | $2,380k | Jun 30, 2019 | Aug 14, 2019 | |
| Altrinsic Global Advisors LLC | 201,360 | $1,832k | Jun 30, 2019 | Aug 14, 2019 |